intravenous
Showing 9976 - 10000 of >10,000
MRI and Computational Simulation Cardiology Study
Enrolling by invitation
- Congenital Heart Disease
- Pulmonary Hypertension
- Magnetic Resonance Imaging
-
Palo Alto, CaliforniaLucile Packard Children's Hospital at Stanford
Sep 15, 2021
Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type II Trial in Worldwide (Apitegromab)
Not yet recruiting
- Spinal Muscular Atrophy
- +9 more
-
Phoenix, Arizona
- +26 more
Nov 15, 2022
COVID-19 Trial in France (hospitalized children with Covid19)
Recruiting
- COVID-19
- hospitalized children with Covid19
-
Saint Denis, La Réunion, France
- +75 more
Nov 21, 2022
Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in
Recruiting
- Recurrent Acute Leukemia
- +16 more
- Acetaminophen
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Diabetic Foot Osteomyelitis Trial (Stimulan-VG, Systemic Antibiotics)
Not yet recruiting
- Diabetic Foot Osteomyelitis
- Stimulan-VG
- Systemic Antibiotics
- (no location specified)
Sep 15, 2022
Neuroimaging Ancillary Study
Not yet recruiting
- Iron Deficiency Anemia
- +5 more
- Ferric carboxymaltose
- +2 more
-
Belgaum, Karnataka, IndiaJawaharlal Nehru Medical College
Sep 14, 2022
Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)
Not yet recruiting
- Hepatocellular Carcinoma
- HAIC(FOLFOX)
- +5 more
- (no location specified)
Aug 16, 2022
Prostate Cancer Trial in Seoul (Ga-68 PSMA-11 PET/CT imaging)
Active, not recruiting
- Prostate Cancer
- Ga-68 PSMA-11 PET/CT imaging
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Sep 27, 2021
Ischemic Stroke Trial in Dijon (prise de sang, quality of life questionnaire)
Completed
- Ischemic Stroke
- prise de sang
- quality of life questionnaire
-
Dijon, FranceCHU Dijon Bourgogne
Nov 24, 2021
Outcomes Study (FIGARO)
Completed
- Primary Immunodeficiency
- Secondary Immune Deficiency
- HyQvia
-
Paris, France
- +3 more
Mar 18, 2022
Biliary Tract Carcinoma Trial in China (Pembrolizumab, Gemcitabine, Cisplatin)
Active, not recruiting
- Biliary Tract Carcinoma
- Pembrolizumab
- +3 more
-
Hefei, Anhui, China
- +21 more
Aug 16, 2022
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Niraparib, Dostarlimab, Radiation)
Active, not recruiting
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Niraparib
- +2 more
-
Boston, Massachusetts
- +2 more
Oct 18, 2021
d to Treat Drug Sensitive Tuberculosis in Breastfeeding
Recruiting
- Tuberculosis Active
- +2 more
- First line tuberculosis treatment
-
Kampala, UgandaInfectious Diseases Institute
Apr 22, 2023
Molecular Culture for the Diagnosis of Pediatric Sepsis
Not yet recruiting
- Sepsis
- +5 more
- Molecular Culture
- (no location specified)
Aug 29, 2023
Lumbar Disc Herniation Trial in Bani Suwayf (transforaminal epidural injection., micro RNA-155 serum level)
Recruiting
- Lumbar Disc Herniation
- transforaminal epidural injection.
- micro RNA-155 serum level
-
Banī Suwayf, Beni-Suef, EgyptMona Hussein
Nov 19, 2022
Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028, Salvage Chemotherapy)
Recruiting
- Acute Myeloid Leukemia (AML)
- SKLB1028
- Salvage Chemotherapy
-
Chengdu, Sichuan, ChinaWest China hospital of Sichuan University
Nov 1, 2021
Acute Ischemic Stroke Trial in Beijing (Shuxinin injection, Basic treatment, Placebo)
Recruiting
- Acute Ischemic Stroke
- Shuxinin injection
- +2 more
-
Beijing, ChinaPeking University Third Hospital
Jul 4, 2021
Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic
Recruiting
- Pancreas Adenocarcinoma
- Resectable Pancreatic Cancer
- Gemcitabine 1000 mg
- +2 more
-
Loma Linda, CaliforniaLoma Linda University Health
Jun 14, 2022
Hypotension on Induction Trial (Remimazolam bolus, Remimazolam continuous)
Not yet recruiting
- Hypotension on Induction
- Remimazolam bolus
- Remimazolam continuous
- (no location specified)
Sep 12, 2022
Acute Anterior or Posterior Cerebral Artery Occlusion
Completed
- Ischemic Stroke
- Thrombi
-
Paris, Ile-de-France, FranceHôpital Fondation Adolphe de Rothschild
Dec 9, 2022
Triple Negative Breast Cancer, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma Trial in United Kingdom
Recruiting
- Triple Negative Breast Cancer
- +3 more
- Modi-1/Modi-1v
- +2 more
-
Brighton, Default, United Kingdom
- +13 more
Nov 18, 2022